Segment and Enterprise Wide Disclosures

3 Months Ended

Jun. 30, 2016

Segment Reporting [Abstract]

Segment and Enterprise Wide Disclosures

Note 9. Segment and Enterprise Wide Disclosures

The Company operates in one business segment—the research, development and sale of medical devices to assist or replace the pumping function of the failing heart. The Company’s chief operating decision maker (determined to be the Chief Executive Officer) does not manage any part of the Company separately, and the allocation of resources and assessment of performance are based on the Company’s consolidated operating results. International sales (sales outside the U.S. and primarily in Europe) accounted for 9% and 8% of total product revenue during the three months ended June 30, 2016 and 2015, respectively. The Company’s long-lived assets, which are its property, plant and equipment, are located primarily in the U.S. except for $6.4 million and $5.9 million at June 30, 2016 and March 31, 2016, respectively, which are located primarily in Germany.